PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Anti-β-Amyloid, 1-16, 1 ml
Anti-β-Amyloid, 1-16, 200 μl
Anti-β-Amyloid, 1-16, 500 μl
Anti-β-Amyloid, 17-24, 1 ml
Anti-β-Amyloid, 17-24, 200 μl
Anti-β-Amyloid, 17-24, 500 μl
APC anti-Annexin A1, 100 tests
APC anti-Annexin A1, 25 tests
APC anti-Baculovirus envelope gp64, 100 μg
APC anti-Baculovirus envelope gp64, 25 μg
APC anti-CD105 (Endoglin), 100 tests
APC anti-CD105 (Endoglin), 25 tests
APC anti-complement C3b/iC3b, 100 tests
APC anti-complement C3b/iC3b, 25 tests
APC anti-human CD230 (Prion), 100 tests
APC anti-human CD230 (Prion), 25 tests